A structured report and advisory service auditing your trust’s commercial opportunities across five core pillars of innovation and digital health, education and training, private patients and international, and research and IP. 

A board-ready action plan, including:

• Commercial opportunity audit: A structured review of current commercial activities, existing pipeline, and key assets across the five pillars.
• Legal and regulatory framework: A clear guide to each trust’s powers and constraints under NHS legislation, provider licence, competition law, data protection, procurement rules, and subsidy control – tailored to each trust.
• Barrier and enabler analysis: An honest assessment of the cultural, structural, and financial barriers holding commercialisation activity back, with practical mitigation strategies.
• Prioritisation matrix: A RAG-rated, scored matrix ranking opportunities by strategic fit risk profile ease of implementation, and timescale.
• Structural analysis: Analysis on the best way of structuring the commercial activity across your options and against agreed board/trust objectives.

International partnerships offer NHS trusts a powerful route to commercial income, enhanced reputation, and global clinical impact. But they are complex – legally, commercially, and reputationally. We help you navigate that complexity with confidence.

The international partnering report

A clear, practical, board-ready report covering everything your trust needs to understand from a legal and regulatory, commercial and risk perspective before entering an international partnership:

• Partnership structures explained: From clinical services agreements and management consultancy arrangements to joint ventures, IP licensing, and brand partnerships, with plain-English guidance on when each is appropriate.
• Strategic and commercial considerations: Governance, resource, partner selection, financial structuring, reputational risk, and exit planning.
• Legal risks and mitigations: Governing law, overseas regulation, UK NHS compliance, data protection, IP protection, employment and secondment, anti-bribery, sanctions, and enforceability.

When you are ready to move from strategy to action, our team provides end-to-end legal and commercial support. 

NHS and public sector innovations often struggle to scale due to regulatory complexity, unclear IP ownership, fragmented support, and limited technical capability.

Our solution

Our Spin-out as a Service model – delivered in partnership with Blüm Health – addresses this by providing a complete pathway from concept to scalable company, combining legal, technical, and commercial expertise in one co-ordinated model.

What clients receive

Clients receive an investor-ready entity with protected IP, regulatory clearance, a go-to-market roadmap, sustainable governance structures and a secure technology platform.

How we work with you

Our engagement model follows three clear stages:

Diagnose: Assessment and readiness (4-6 weeks).

Build: Formation and delivery (6-12 weeks).

Scale: Launch and growth (ongoing).

Results

This structured approach delivers up to 40% faster timelines, improved investor confidence, reduced risk, and higher early-stage valuations.